Translate Bio, Inc. Common Stock
TBIO
TBIO was delisted on the 13th of September, 2021.
145 hedge funds and large institutions have $1.85B invested in Translate Bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 41 increasing their positions, 55 reducing their positions, and 30 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
68% more capital invested
Capital invested by funds: $1.1B → $1.85B (+$747M)
1% less funds holding
Funds holding: 146 → 145 (-1)
1% less call options, than puts
Call options by funds: $9.87M | Put options by funds: $9.95M
3% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 30
25% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$122M |
| 2 |
JP Morgan Chase
New York
|
+$9.88M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$8.88M |
| 4 |
Morgan Stanley
New York
|
+$6.97M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$4.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$72.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$17.6M |
| 3 |
Goldman Sachs
New York
|
-$11.1M |
| 4 |
AG
Artal Group
Luxembourg
|
-$9.83M |
| 5 |
Millennium Management
New York
|
-$4.76M |
TBIO Hedge Fund Activity: Q2 2021 in Review
145 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q2 2021, worth a combined $1.85B — up 68% from $1.1B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of TBIO and 29 opened new positions — a net loss of 1 holder — while 55 trimmed existing stakes and 41 added.
The largest buyer was Fidelity Investments, adding an estimated $122M. The largest seller was RTW Investments, exiting entirely with an estimated $72.3M sold.
- 145 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q2 2021, down from 146 in Q1 2021.
- Funds reported $1.85B of Translate Bio, Inc. Common Stock stock for Q2 2021, up 68% quarter-over-quarter.
- 29 funds opened new Translate Bio, Inc. Common Stock positions in Q2 2021 and 30 closed out, a net change of -1 holder.
- The largest Translate Bio, Inc. Common Stock buyer in Q2 2021 was Fidelity Investments, an estimated $122M added.
- The largest Translate Bio, Inc. Common Stock seller in Q2 2021 was RTW Investments, an estimated $72.3M sold.
Based on aggregated 13F filings for Q2 2021.